SCHEMBL21165185

SCHEMBL21165185

Cc1cc(C(O)CN2CCCC2)c(C)n1-c1ccc(F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
USP14 P54578 2/20 0.40
USP7 Q93009 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
USP5 P45974 1/20 0.39
RAB9A P51151 1/20 0.39
S1PR4 O95977 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
DRD2 P14416 2/20 0.36
HTR1A P08908 1/20 0.36
HTR7 P34969 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
MAOB P27338 1/20 0.35
HTR2A P28223 1/20 0.35
HRH1 P35367 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
S1PR1 P21453 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921452 0.84 USP14 (0.56) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL19501173 0.76 SMN1; SMN2 (0.53) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL23559540 0.74 SMN1; SMN2 (0.49) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL21165029 0.74 HPGD (0.45) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL6921676 0.74 USP14 (0.72) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL23559501 0.73 SMN1; SMN2 (0.48) KDM4EUSP14USP7SMN1; SMN2NPC1
SCHEMBL21165030 0.71 NOTUM (0.48) USP14USP7SMN1; SMN2HPGDHTR7
SCHEMBL12781762 0.70 L3MBTL1 (0.44) KDM4ESMN1; SMN2L3MBTL1MAOB
SCHEMBL19749177 0.67 GAA (0.46) KDM4ESMN1; SMN2HPGDRAB9AL3MBTL1
SCHEMBL12074443 0.65 L3MBTL1 (0.54) KDM4EL3MBTL1DRD2MAOBHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351568-B2 Compositions and methods for enhancing proteasome activity PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2019-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351568-B2 Compositions and methods for enhancing proteasome activity PSMG3, PSME3, PSMB11 KDM4E 2300/4885USP14 12/4885USP7 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.